Albireo Pharma Inc (ALBO.OQ)
ALBO.OQ on NASDAQ Stock Exchange Capital Market
32.74USD
6:13pm BST
32.74USD
6:13pm BST
Change (% chg)
$-0.31 (-0.94%)
$-0.31 (-0.94%)
Prev Close
$33.05
$33.05
Open
$32.99
$32.99
Day's High
$33.31
$33.31
Day's Low
$32.46
$32.46
Volume
9,015
9,015
Avg. Vol
18,691
18,691
52-wk High
$39.67
$39.67
52-wk Low
$15.31
$15.31
Select another date:
Mon, Mar 19 2018
BRIEF-Albireo Pharma Inc Files For Non-Timely 10-K
* ALBIREO PHARMA INC FILES FOR NON-TIMELY 10-K WITH THE U.S. SEC Source text: (http://bit.ly/2pobWiJ) Further company coverage:
BRIEF-Albireo Reports Fourth Quarter And Year-End 2017 Financial Results
* ALBIREO REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS
BRIEF-Albireo Prices $65.0 Mln Public Offering Of Common Stock
* ALBIREO PRICES $65.0 MILLION PUBLIC OFFERING OF COMMON STOCK
BRIEF-Albireo Pharma Says Elobixibat Approved In Japan For Treatment Of Chronic Constipation
* ALBIREO TO RECEIVE MORE THAN $55 MILLION(1) IN NONDILUTIVE CASH PAYMENTS
BRIEF-Albireo Announces Agreement With Healthcare Royalty Partners
* ALBIREO ANNOUNCES ROYALTY MONETIZATION AGREEMENT WITH HEALTHCARE ROYALTY PARTNERS FOR ELOBIXIBAT IN JAPAN
BRIEF-Albireo posts Q3 loss per share $0.73
* Albireo Pharma Inc - decision on potential approval of elobixibat in Japan expected in first half of 2018
BRIEF-Albireo Pharma to present final results of phase 2 study of A4250 in children with cholestatic liver disease
* Final results of Albireo’s phase 2 study of A4250 in children with cholestatic liver disease presented at the liver meeting 2017
Select another date: